We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KEX:NYSEKirby Corporation Analysis

Data as of 2026-05-21 - not real-time

$148.69

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kirby Corp. delivered a robust Q1, with revenue up roughly 7% year‑over‑year and GAAP EPS beating consensus by over 8%, underscoring the resilience of its domestic tank‑barge franchise. Operating margins remain healthy around 13% and free cash flow is positive, supporting the company’s ability to fund growth without relying on dividends. Technically, the stock trades above its 20‑day and 50‑day moving averages, indicating a bullish bias, while the RSI hovers near the 60‑point mark, suggesting modest upward momentum. However, the MACD histogram has turned negative and volume trends are declining, pointing to potential short‑term pressure near the $140 support level.
Valuation appears stretched: the market price sits well above the DCF‑derived fair value, implying an overvalued stance despite a trailing P/E that is below the industry average. The absence of a dividend eliminates income‑focused appeal, and the “Extreme Greed” sentiment in the fear‑greed index signals heightened market optimism. Risk factors are moderate, with low beta, 21% 30‑day volatility, and a primarily U.S. operational footprint, while liquidity concerns arise from the decreasing volume trend.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with decreasing volume
  • Negative MACD histogram indicating short‑term weakness
  • Strong recent earnings beat supporting price stability

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained revenue and earnings growth trajectory
  • Operating margins and cash flow generation
  • Market positioning in a niche domestic marine transport segment

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation premium relative to DCF fair value
  • Absence of dividend reduces total return appeal
  • Fundamental strengths balanced by moderate volatility and sector cyclicality

Key Metrics & Analysis

Financial Health

Revenue Growth7.40%
Profit Margin10.51%
P/E Ratio22.9
ROE10.69%
ROA5.27%
Debt/Equity34.68
P/B Ratio2.3
Op. Cash Flow$731.3M
Free Cash Flow$355.0M
Industry P/E29.5

Technical Analysis

TrendBullish
RSI59.7
Support$140.14
Resistance$157.69
MA 20$147.04
MA 50$140.28
MA 200$114.90
MACDBearish
VolumeDecreasing
Fear & Greed Index90.29

Valuation

Fair Value$95.60
Target Price$166.33
Upside/Downside11.87%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.71
Volatility21.43%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.